Cancer Research and Treatment10.4143/crt.2017.1252018502356-365Omic Approach in Non-smoker Female with Lung Squamous Cell Carcinoma Pinpoints to Germline Susceptibility and Personalized MedicineMargherita Baldassarri, Chiara Fallerini, Francesco Cetta, Marco Ghisalberti, Cristiana Bellan, Simone Furini, Ottavia Spiga, Sergio Crispino, Giuseppe Gotti, Francesca Ariani, Piero Paladini, Alessandra Renieri, Elisa Frullanti,,
Respirology10.1111/resp.14150_698202126S3360-360P8‐186: Squamous cell carcinoma of lung in non‐smoker women,,
Pharmacogenomics and Personalized Medicine10.2147/pgpm.s242582012113Personalized medicine and treatment approaches in non-small-cell lung carcinomaHossein Borghaei
Lung Cancer10.1016/s0169-5002(10)70037-4201067S12Small cell lung carcinoma following adjuvant breast radiotherapy in a non-smokerC.E. Davies, M.R. Button, J.F. Lester,
Lung Cancer10.1016/0169-5002(92)90132-4199282126Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose,
Lung Cancer10.1016/0169-5002(93)90533-4199385-6337Allelotype of non-small cell lung carcinoma - Comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma,
Journal of Personalized Medicine10.3390/jpm12101684202212101684Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex TestingNina Pujol, Simon Heeke, Christophe Bontoux, Jacques Boutros, Marius Ilié, Véronique Hofman, Charles-Hugo Marquette, Paul Hofman, Jonathan Benzaquen
Journal of Personalized Medicine10.3390/jpm110201542021112154Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell CarcinomaTalip Zengin, Tuğba Önal-Süzek
Clinical Lung Cancer10.3816/clc.2006.n.050200683214-216Response to Erlotinib in First-Line Treatment of Non–Small-Cell Lung Cancer in a White Male Smoker with Squamous-Cell HistologyMihaela Achille, Marielle Gallegos-Ruiz, Giuseppe Giaccone, Jean-Charles Soria,
Lung Cancer10.1016/0169-5002(91)91967-g19917165Patients with non-resectable squamous cell carcinoma of the lung. A prospective, randomized study,